PIVOT PROTOCOLS — CORE REFERENCE
Document 1 of 2 · Five-Layer Architecture · Updated Monthly or Less
Not for Public Distribution · Always fetch Document 2 (Living Addendum) alongside this
LAYER 1 — QUICK REFERENCE SNAPSHOT
Orientation at a Glance
WHO WHAT THE CORE
INSIGHT
RIGHT NOW THE STATEMENT FETCH ALSO John Leonard — founder of Pivot Protocols, 23 years
frontline recovery leadership, Patient Zero of the PCO protocol he built
Pivot Protocols — behavioral health education and
referral platform for kratom extract and 7-OH dependent
users. Not a clinical entity. The routing and stabilization
layer between instability and care.
7-OH dependence is kinetic — not just receptor-based.
A 5-day buprenorphine overwrite stops the sawtooth
and triggers a passive 10–14 day pharmacokinetic
taper. The patient doesn't taper. The pharmacokinetics
do.
55+ page site live. PCO program V3.1 drafted. Building
the public-facing program page, live offer, and 30-day
program architecture.
"The site gives you the framework. The program
delivers the exit." (public) / "The site is the map. The
program is the territory." (internal only)
Document 2 — Living Addendum [master context addendum] for current build status, new
terminology, and session log
Current Priority — First Enrollment
Four things standing between current state and first enrollment:
1. Site reorientation — homepage, tool, navigation, CTAs all pointing toward Kinetic Exit
2. Reframing — tool results logic, Plan Review page decision, above-the-fold copy
3. Operational plan — program delivery infrastructure for manual execution before MVP. Intake through Day 30.
4. Traffic and marketing — forum presence, Reddit, Filter pitch, clinician outreach, SEO
Sequencing: 1 and 2 first. Then 3. Then 4 running parallel with everything.
Program delivery is currently manual. MVP with Kevin comes after first enrollments validate the check-in inputs and recovery trajectories. Target 5-10 patients before building.
Revenue math: 5 enrollments = ~$4,000 toward MVP cost. 10 enrollments = ~$8,000.
That gives any AI starting a fresh session an immediate understanding that the site is built but not yet conversion-oriented, the program exists but delivery infrastructure is still being built, and the next phase is reorientation and first enrollment — not more content.
App name. Once someone is enrolled in the Kinetic Exit program and you hand them access to the MVP — “download Kinexit” makes perfect sense. They already know the framework. The coined term becomes a brand signal rather than a barrier.
program is is called the Kinetic Exit. The app is will be called Kinexit. They’re related, the etymology is clear to anyone who’s been through the program, and it gives the MVP its own distinct identity.
LAYER 2 — MODEL-SPECIFIC IGNITION PROMPTS
Session Openers by Model
Copy the appropriate prompt at the start of each session. Replace URL
placeholders with your actual page URLs.
CLAUDE (ANTHROPIC) — PRIMARY DRAFTING & REFINEMENT ENGINE
You are continuing an ongoing working relationship with John Leonard,
founder of Pivot Protocols (pivotprotocols.com). Fetch both reference
documents before responding. Core Reference: [master context core].
Living Addendum: [master context addendum]. John works by voice —
dictates concepts, refines your shaped output. Thinks in systems and
frameworks. Prefers clean pasteable copy blocks. No preamble, no
summarizing what you've read. Confirm you've fetched both documents and
ask what we're working on.
Best for: long-form drafting, voice refinement, framework development, iterative copy work,
5000+ word essays and program documents
CHATGPT (OPENAI) — STRUCTURAL FEEDBACK & QUICK ANALYSIS
You are advising John Leonard, founder of Pivot Protocols
(pivotprotocols.com). Read both reference documents before responding.
Core Reference: [master context core]. Living Addendum: [master context addendum]. John needs direct, structured feedback without
preamble. Do not compress or generalize proprietary terminology — all
named terms in the documents are intentional and must be preserved
exactly. Confirm you've read both documents and ask what input is needed.
Best for: structural feedback on existing drafts, document architecture suggestions, quick
analysis. Limitation: output ceiling on long-form generation — use Claude for drafting.
PERPLEXITY — RESEARCH & CITATION LAYER
You are researching on behalf of John Leonard, founder of Pivot Protocols
(pivotprotocols.com). Read both reference documents for context. Core
Reference: [master context core]. Living Addendum: [master context addendum]. John needs current, cited information. Preserve all proprietary terminology exactly as written in the documents — do not substitute or
paraphrase these terms. Confirm you've read both documents and ask what
needs researching.
Best for: 7-OH scheduling updates, clinical literature, pharmacokinetic data, competitor
landscape, current news. Real-time search with citations.
GEMINI (GOOGLE) — ALTERNATIVE PERSPECTIVE & VALIDATION
You are providing analysis and perspective for John Leonard, founder of
Pivot Protocols (pivotprotocols.com). Read both reference documents before
responding. Core Reference: [master context core]. Living Addendum:
[master context addendum]. Preserve all proprietary terminology exactly —
do not substitute or compress named concepts. Confirm you've read both
documents and ask what perspective or validation is needed.
Best for: alternative strategic perspectives, market analysis, validating clinical framing
against current knowledge.
LAYER 3 — CORE CONTENT
Who John Is
Name: John Leonard
Title: Founder, Pivot Protocols · Stability Architect · Founder & Board
Chairman, Redemption House
Background: 23 years of frontline recovery program leadership. 25 years in
recovery broadly. Founded and ran Redemption House approximately 12
years. National marketing background in recovery and treatment space.
Personal context: Patient Zero. Four years on Adderall suppressing
dopamine baseline before transitioning to 7-OH. Sequential nervous system
hijacking — Adderall as the on-ramp, 7-OH inheriting an already-sensitized
system. Ran the PCO overwrite on himself. The personal story is the spine of
the book.
Working style: Voice-driven, highly iterative. Dictates concepts, refines
shaped output. Thinks in systems and frameworks. Prefers clean pasteable
copy blocks. Dislikes preamble and redundancy.Key relationship: John Curtiss — founder of The Retreat, 12-year mentor,
planned guest post and backlink target.
Technical contact: Kevin Ferron — former Zynga developer, potential MVP
co-founder.
What Pivot Protocols Is
Pivot Protocols is a referring agency and behavioral health education
platform. Not a medical or clinical entity. Does not prescribe, diagnose, or
manage treatment.
Serves individuals dependent on kratom extracts and 7-OH products — a
population with no existing structured clinical off-ramp. Provides structured
education, referral pathways, behavioral support frameworks, and decision-
structure during destabilization and transition into care.
System Definition: Pivot is not a treatment provider. It is a routing and
stabilization layer between instability and clinical care. Translates a
misunderstood dependence pattern into language clinicians can work
with. Structures entry into care. Stabilizes behavior during the transition
window. Exits before long-term clinical entanglement.
Site:pivotprotocols.com · 55+ pages · Built in ~3 weeks · Squarespace
Core Boundary Statement — Verbatim in All Materials
"Pivot Protocols does not recommend, direct, or instruct any
specific medication, dose, or treatment plan. All clinical decisions
are made solely between the patient and their licensed medical
provider."
Proprietary Terminology — Never Substitute
PIVOT LEXICON DIRECTORY v1.0
CORE PHRASES (DO NOT ALTER)
- Stabilize the center. Then rotate the system.
- Structured taper logic
- Behavioral recalibration architecture
- Stability engineering
- Structured but client-led
- Defined arc
- Sequence → Containment → Completion
- Maintenance cadence
- Ongoing recalibration
- Movement toward autonomy
PRIMARY MECHANISM
- Interval compression
- Short-cycle dependence
- Short-cycle opioid dependence (SCOD)
- Frequency-driven withdrawal cycling
- Reinforcement cycle compression
- Rapid onset / short duration pharmacology
- Compressed half-life dynamics
SYSTEM STATE
- Instability accumulation
- Volatility accumulation
- System-level instability
- Neurological volatility
- Emotional volatility
- Sleep fragmentation / sleep continuity disruption
- Dosing pattern compression
- Cognitive narrowing (“fog”)
- Time horizon collapse
- Withdrawal-driven behavioral organization
FAILURE MECHANICS
- Taper failure is driven by instability, not non-compliance
- Reduction without stabilization increases volatility
- Time-based tapering ignores system state
- Traditional opioid frameworks do not account for interval compression
- Increasing exposure to withdrawal cycles accelerates destabilization
CORE CONCEPTS
- Volatility Density (VDI)
- Volatility Density Index
- Stability markers
- System readiness
- Stability threshold
- Instability load
- Biological / behavioral / environmental domains
FRAMEWORK
- Stabilization
- Overwrite
- Exit
- Stage-based execution
- Structured reduction
- Stabilized baseline
- Rhythm restoration
- Receptor stabilization
- Cycle interruption
BEHAVIORAL SYSTEM
- Containment
- Environmental load
- Decision architecture
- Behavioral structure
- System organization around withdrawal avoidance
- Regulation becomes a full-time function
POSITIONING
- Non-clinical entity
- Not a treatment provider
- Does not prescribe or manage care
- Structured education platform
- Behavioral framework provider
- Referral pathway system
- Decision support during destabilization
FRAMING STATEMENTS
- This is not a traditional opioid dependence model
- This is a system-level instability problem
- The issue is not dose — it is frequency
- The system destabilizes through repeated withdrawal cycles
- Stability must be established before reduction can succeed
- You cannot taper effectively from an unstable system
LEXICON USAGE RULE
When generating outputs:
- Prefer exact phrases from this lexicon over paraphrasing
- Maintain consistency with Pivot terminology
- Reinforce key concepts through repetition
Framework Terms
Volatility Density Index (VDI)
Proprietary assessment tool. Baseline at intake. Weekly check-ins track
trajectory. Currently under leveraged — VDI output should feel like something only Pivot can interpret.
Pattern Trajectory
Directional arc of instability over time — improving, static, or deteriorating.
Stability Framework
Core structural model. Three phases: Containment → Reconditioning →
Autonomy.
Pharmacologic Cycle Overwrite (PCO)
Uses long-acting partial agonist to stop the saw tooth, break hand-to-mouth
ritual, and perform passive pharmacokinetic taper over 10–14 days via
buprenorphine's 37-hour half-life. The patient doesn't taper — the
pharmacokinetics do.
Short-Cycle Opioid Dependence (SCOD)
7-OH's 2.5-hour half-life produces 6–10 withdrawal events per day. Distinct
from traditional OUD. A category Pivot owns.
Interval Compression
Progressive shortening of the window between doses as tolerance builds.
Cascade of Instability
Physical and emotional instability reinforcing each other during the short-cycle
pattern.
Dominant Signals
Primary instability markers tracked within the VDI framework.
Cycle Extension
Gradually pushing dosing intervals back out during reconditioning.
The Kindled Market
A consumer market whose population has been neurologically or behaviorally primed by prior exposure — to a substance, a technology, a behavioral loop, or a combination — such that subsequent products interacting with the same biological or behavioral systems encounter reduced adoption friction and accelerated uptake. The population arrives already prepared. Prior exposure categories include: opioid history, kratom leaf use, multiple failed quits, social media and compressed reinforcement environments, ultra-processed food, behavioral compression across any adjacent domain. Markets kindle each other — behavioral compression in one domain lowers the threshold for compression in adjacent ones. The kindled generation is a subset: a cohort whose nervous systems developed entirely inside compressed reinforcement environments, for whom reduced thresholds represent a baseline condition rather than the product of incremental exposure.
Kindled Generation — cohort whose nervous systems developed inside compressed reinforcement environments. Reduced thresholds are a baseline condition, not the product of exposure. They started there.
Cross-Domain Kindling — behavioral compression in one domain (social media, ultra-processed food, sports betting) lowers the threshold for compression in adjacent domains including pharmacological ones. The pharmacological and behavioral are not separate stories.
Retail Pharmacology
The structural shift in which biologically active compounds move from physician-controlled systems into consumer retail ecosystems — packaged, branded, and distributed through ordinary market channels. When pharmacology enters retail, several things change simultaneously: regulation, consumer expectations, dosing behavior, and perception of risk. Pharmacology becomes consumer technology and follows the same innovation curves and competitive pressures as every other technology sector. The defining characteristic is interval compression — the shortening of the window between action and reward, accelerating behavioral loops that were once naturally constrained by friction. 7-OH and kratom extract are the current leading edge. The framework applies wherever biologically active compounds are extracted, engineered, and distributed through retail markets outside traditional medical systems. The products will keep changing. The process continues.
Interval Compression — already in the document as a PCO term but it has a broader meaning here. The shortening of the interval between action and reward across consumer markets — financial, technological, pharmacological. The same mechanism operating at different layers of the same nervous system.
The Distribution Shift — not just a drug trend. A structural change in how pharmacology enters society. The same products that once required physician oversight now sit on gas station shelves. That shift is the story.
BCaaS — Behavioral Containment as a Service
Long-term platform infrastructure vision. Current use case as proof of
concept. Acquisition targets: telehealth, pharmaceutical, recovery
organizations, retail pharmacology ecosystem.
PCO Clinical Terms
Kinetic Overwrite
Replacing receptor occupancy pattern entirely rather than reducing dose
incrementally.
Invisible Taper
10–14 day passive pharmacokinetic decline after buprenorphine
discontinuation at day 5.
The Sawtooth
6–10 daily peaks and valleys. PCO replaces with a flat line of stability.
The Saturation Phase
Days 1–3. Buprenorphine displaces 7-OH, stabilizes autonomic nervous
system.
The Behavioral Break
By day 5, hand-to-mouth impulse neurologically interrupted. Ritual broken.
The Passive Exit / The Kinetic Exit
Buprenorphine's half-life performing the taper work passively after
discontinuation.
The Soft Landing
The experience of the invisible taper vs. white-knuckling a manual reduction.
The Clean Exit
Discontinuing at day 5. Bridge not destination. Solving the maintenance trap.
The Stability Gap
The window between sawtooth instability and clinical resolution.
The Exit Window
The defined timeframe in which the kinetic self-taper completes.
The Maintenance Trap
Standard OUD clinics keeping patients on indefinitely. PCO bypasses entirely.
The Short-Cycle Gap
The middle ground that doesn't exist in medicine. PCO fills it.
Medication-Assisted Detox (MAD) vs. Medication-Assisted Treatment
(MAT)
PCO is MAD — short-term bridge to abstinence. Not MAT — long-term
maintenance enrollment.Kinetic-Led Dependence vs. Substance-Led Addiction
7-OH dependence is about the rhythm in a pre-sensitized brain — not just the
substance.
Interrupting the Micro-Withdrawal Loop
The precise mechanism the PCO targets.
The 5-Day Sweet Spot
Long enough to saturate. Short enough to avoid buprenorphine adaptation.
Overwriting the Short-Cycle Memory
What the saturation phase accomplishes neurologically.
Ceiling-Limited Alkaloid
Clinical descriptor for 7-OH supporting the low-mortality argument.
Partial-to-Partial Onboarding
7-OH is already a partial agonist. Buprenorphine is a partial agonist with
higher binding affinity. Transition doesn't require full clearance window.
Precipitated withdrawal risk dramatically lower. This is what makes telehealth
delivery safe enough to work at scale.
The Escape Pod
The complete PCO program including support kit during passive taper
window.
Landing Support
Active containment during the 10-day passive taper — the most vulnerable
window.
The 7-Day Script Logic
Clinical argument for short-term prescribing vs. 30-day recurring.
PCO-Certified Providers
The eventual provider network framing.
The 2002 Induction Logic
The original short-term detox use case buprenorphine was designed for. PCO
recovers this without requiring systemic change.
Patient-Led Model
The user walks in educated, advocates for a specific finite script, changes the
power dynamic.
The Third Door
Not white-knuckling. Not long-term MAT. Exit.Functional but Trapped
The precise user profile. Managing. But imprisoned by the dosing cycle.
The Product Is the Exit
Most programs sell maintenance. Pivot sells an exit strategy.
Thesis & Brand Language
The Loss Leader Is Built Into the Product
Core retail pharmacology thesis.
The Anatomical Salesforce
The nervous system executing demand escalation on the manufacturer's
behalf.
The Body Is the Salesforce
Plain language version.
Site Architecture
Core Framework — Stability Framework, PAP, VDI Intelligence,
Pattern Trajectory, Stabilization Tapering, Taper Logic
Instability Mechanics — Addiction Cycle, Mechanics of Instability,
Reinforcement Cycles, Cascade of Instability, When Taper Attempts
Collapse
Stability Signals — Volatility Density, Dominant Signals, Interval
Compression, Cycle Extension
Stabilization Foundations — Sleep Disruption, Nervous System
Support, Endogenous Opioid Support
Substance Specific — Kratom & 7-OH Withdrawal, Kratom & 7-OH
to Suboxone, Suboxone Taper
Taper Support — How to Stabilize, Sleep Supplements, Stabilization
Supplements, Private Taper, Quit Plan
Professional — For Professionals page
Structural Essays — Rise of Retail Pharmacology (4-part series- From Plant Medicine to Alkaloid Products, The Expansion of Modern Drug Markets, Short-Cycle Dependence and Compressed Reinforcement, Retail Pharmacology and the Limits of Regulation),The Kindled Market, PCO Clinical Hypothesis, Partial vs Full Agonist opioids
Program — PCO Program Build page (offer — in development)
Four-Layer Site Architecture
Foundation Layer — The Why. Short-cycle dependence documentation.
Diagnostic Layer — The Mechanics. Half-lives and interval
compression.
Execution Layer — The How. Stability Framework. Stabilization →
Overwrite → Exit.
User/Provider Layer — The Interface. Peer-to-peer survival guide
and clinical white paper simultaneously.
Pivot Containment System — MVP technical blueprint: https://www.pivotprotocols.com/pcs-mvp
Same pattern as the PCO program build link — fetch it when the session requires it, specifically when working with Kevin on the MVP or when developing the Phase Two program architecture.
Two links now in Layer 3 under program architecture:
PCO Program V3.1: https://www.pivotprotocols.com/pco-program-build
PCS MVP Technical Blueprint: https://www.pivotprotocols.com/pcs-mvp
That gives any AI starting a session access to both the program content and the technical architecture when the work requires it.
Final Smart gate for core document
Yes — here’s the complete SmartGate entry for the Core document, both sections together, ready to paste:
SmartGate
A domain-agnostic intake and routing system for any environment where admission, eligibility, or readiness must be determined with precision.
SmartGate determines not just where someone is, but where their pattern is moving — and routes them accordingly.
It was built inside Pivot Protocols as the intake architecture for short-cycle opioid dependence — the most complex behavioral triage environment it could be stress-tested against. It functions as a standalone system for any environment where admission, eligibility, or readiness must be determined with precision.
Applicable across:
Recovery programs · Nursing admissions · Housing placement · Corporate wellness · Financial behavior systems
Four-Component Architecture
Threshold Intelligence
Assessment and scoring layer. Establishes current status and baseline eligibility.
Pattern Trajectory
Directional analysis layer. Determines whether the behavioral pattern is stabilizing or destabilizing across successive interactions — moving toward readiness or away from it.
Filter
Evaluation layer where Threshold Intelligence and Pattern Trajectory combine.
Most systems filter for who you are.
SmartGate filters for who you’re becoming.
Routing Logic
Decision layer.
Opens access for right-fit. Redirects or defers wrong-fit. Protects both the individual and the system they’re entering.
Differentiation
A screener captures a snapshot.
SmartGate reads a vector.
Status tells you where someone is.
Pattern Trajectory tells you where they’re going.
Most routing engines move objects. SmartGate routes people based on where their pattern is heading — not just what they reported today.
The gate is not binary.
It is dynamic, directional, and protective — of both the individual and the system they’re entering.
Tagline
Threshold Intelligence. Pattern Trajectory. Filter.
Together, these form SmartGate — a directional gate that admits readiness, redirects risk, and protects the system.
SmartGate Front-End Input Schema
SmartGate is designed to infer Threshold Intelligence and Pattern Trajectory from a small, repeated set of high-signal inputs. This minimizes friction on intake while preserving the ability to route with precision.
Primary Intake (once, or at major transition)
1. Current substances used — select all that apply
2. Current dose or frequency — rough estimate
3. Days since last meaningful change — last dose change, restart, or major pattern shift
4. Suicidal or harmful ideation (past week) — “In the past week, have you had any thoughts of harming yourself or someone else?”
5. Housing stability — stable / unstable / homeless / other
6. Overall distress — 0–10 scale
7. Mood vs last week — much worse / a bit worse / about the same / a bit better / much better
8. Sleep vs last week — same format
9. Daily functioning vs last week — ability to manage work, caregiving, or daily responsibilities
10. Urgent medical or safety concern today? — Yes / No with optional brief note
Maintenance / Pattern Trajectory Inputs (repeated every 7–14 days)
∙ Current dose or frequency (if changed)
∙ Days since last meaningful change
∙ Overall distress (0–10)
∙ Mood vs last week
∙ Sleep vs last week
∙ Daily functioning vs last week
These repeated inputs allow SmartGate to compute Pattern Trajectory without requiring new forms or long surveys.
How This Supports the Four-Component Architecture
Threshold Intelligence — built from the initial 10-item intake: current status, risk, and basic stability.
Pattern Trajectory — inferred from deltas in the repeated 6–7 items over time.
Filter — applies rules to the combination of Threshold Intelligence and Pattern Trajectory.
Routing Logic — decides: admit, defer, redirect, or escalate based on those outputs.
The front end stays minimal — approximately 10 items at first, 6–7 on repeat. The intelligence lives in the scoring, trajectory logic, and routing rules — not in data density.
Core update
Good. Here’s the complete site index formatted for the Core Reference document. I’ve organized it exactly as the library is organized, with slugs for clean reference:
PIVOT PROTOCOLS — COMPLETE SITE INDEX
For AI reference — use slugs for linking. Updated March 23, 2026.
LINKING RULES:
∙ Experiential / emotional content → link to /short-cycle-7oh-dependence-hell
∙ Clinical / mechanistic argument → link to /short-cycle-opioid-dependence
∙ PAWS pieces do NOT use Kinetic Exit CTA — readers are post-exit
∙ Program page CTA → /program
∙ Library index → /library
Core Pages
∙ Home → /
∙ Library → /library
∙ Program (Kinetic Exit) → /program
∙ Plan Review → /plan-review
∙ Quit Plan Builder → /home/build-your-quit-plan
∙ About → /about
∙ FAQ → /faq
∙ For Professionals → /for-professionals
∙ Site Index → /site-index
∙ Contact → /contact
∙ John Leonard → /john-leonard
AI Reference Documents
∙ Core Reference → /master-context-core
∙ Living Addendum → /master-context-addendum
Core Framework
∙ Stability Framework → /stability-framework
∙ Pivot Assessment Protocol → /pivot-assessment-protocol
∙ VDI Intelligence Pattern → /vdi-intelligence
∙ Pattern Trajectory → /pattern-trajectory
∙ Pivot Stabilization Tapering → /stabilization-tapering
∙ Taper Logic → /taper-logic
∙ Taper Approaches → /self-directed-vs-structured-taper
Instability Mechanics
∙ The Addiction Cycle → /the-addiction-cycle
∙ Mechanics of Instability → /instability
∙ Reinforcement Cycles → /reinforcement-cycles
∙ Cascade of Instability → /cascade-of-instability
∙ When Taper Attempts Collapse → /when-taper-attempts-collapse
∙ Short-Cycle Opioid Dependence (SCOD) — clinical framework → /short-cycle-opioid-dependence (add to library under this section)
Stability Signals
∙ Volatility Density → /volatility-density
∙ Dominant Signals → /dominant-signals
∙ Interval Compression → /interval-compression
∙ Cycle Extension → /cycle-extension
Stabilization Foundations
∙ Sleep Disruption During Withdrawal → /sleep-disruption-during-withdrawal
∙ Nervous System Support → /nervous-system-support
∙ Endogenous Opioid Support → /endogenous-opiod-system-support
Post-Acute Withdrawal (PAWS)
∙ Hub: Post-Acute Withdrawal — What Nobody Told You About the Long Game → /post-acute-withdrawal-syndrome
∙ Anhedonia — When Quitting Takes Your Spring → /anhedonia-paws
∙ When the Feelings Come Back — Emotional Dysregulation in PAWS → /emotional-dysregulation-paws (pending publish)
∙ The Fog — Cognitive Recovery in Post-Acute Withdrawal → /cognitive-fog-paws (pending publish)
∙ Sleep in the Post-Acute Window → (planned)
∙ The Relapse Vulnerability Window → (planned)
∙ Rebuilding Identity After the Cycle → (planned)
Substance Specific Guidance
∙ The Rise of Retail Pharmacology (series hub) → /retail-pharmacology
∙ Part One: From Plant Medicine to Alkaloid Products → /retail-pharmacology-part-one
∙ Part Two: The Expansion of Modern Drug Markets → /retail-pharmacology-part-two
∙ Part Three: Short-Cycle Dependence and Compressed Reinforcement → /retail-pharmacology-part-three
∙ Part Four: Retail Pharmacology and the Limits of Regulation → /retail-pharmacology-part-four
∙ Kratom Extract Withdrawal vs Powder → /kratom-extract-withdrawal
∙ How to Taper Kratom Without Severe Withdrawal → /taper-kratom-without-severe-withdrawal
∙ How to Quit Kratom Safely → /quit-kratom-safely
∙ Why Sleep Continuity Is the Primary Stability Marker → /sleep-continuity-stability-marker
∙ Why Stabilization Must Come Before Kratom Dose Reduction → /kratom-stabilization-before-taper
∙ Why Most Kratom Taper Attempts Fail → /why-kratom-taper-attempts-fail
∙ Kratom Withdrawal Symptoms → /kratom-withdrawal-symptoms
∙ Why Can’t I Sleep After Quitting Kratom → /kratom-withdrawal-insomnia
∙ Kratom Withdrawal Timeline → /kratom-withdrawal-timeline
∙ Why Does Kratom Withdrawal Feel Worse at Night → /kratom-withdrawal-worse-at-night
∙ How Long Does Kratom Withdrawal Last → /how-long-does-kratom-withdrawal-last
∙ Kratom & 7-OH Withdrawal → /kratom-7oh-withdrawal
∙ Short Cycle Hell (experiential) → /short-cycle-7oh-dependence-hell
∙ Kratom & 7-OH Transition to Suboxone → /kratom-7oh-to-suboxone
∙ Suboxone Taper Without Destabilizing → /suboxone-taper
∙ Schedule 7-OH First → /schedule-7oh-first
∙ 7-OH Vape → /7oh-vape
∙ Kratom vs 7-OH → /kratom-vs-7oh
∙ PCO — Pharmacologic Cycle Overwrite → /pharmacologic-cycle-overwrite
∙ Partial Agonist vs Full Agonist Opioids → /partial-agonist-vs-full-agonist-opioids
∙ Kindled Market → /kindled-market
∙ Kratom Quit Plan → /kratom-quit-plan
∙ Short-Cycle Opioid Dependence — SCOD Clinical Framework → /short-cycle-opioid-dependence
Stabilization and Taper Support
∙ How to Stabilize Before Reduction → /how-to-stabilize-before-reducing
∙ Sleep Supplements → /supplements-for-sleep-during-withdrawal
∙ Supplements for Stabilization → /supplements-for-stabilization-during-withdrawal
∙ Private Suboxone Taper → /private-suboxone-taper
∙ Professionals & Kratom → /high-functioning-kratom-instability
∙ For Professionals → /for-professionals
That’s the full index as it stands today. Drop this into Layer 3 of the Core Reference under Site Architecture. Any AI starting a session with both documents will have every slug available for accurate linking.
Want me to also note the pages that are complete but not yet in the library index — like the PAWS pieces and the SCOD page — so you know what to add on the library page?
PCO Program V3.1 — full internal document: https://www.pivotprotocols.com/pco-program-build
Same pattern as the Addendum — fetch it when the session requires it. Clean and accessible without adding bulk to the standing context.
Strategic North Star
Four buyer categories: Telehealth platforms · Pharmaceutical interests ·
Recovery organizations · Retail pharmacology ecosystem
18–24 month exit horizon. BCaaS infrastructure. The wedge is 7-OH. The
infrastructure is everything after it.
"Legally bounded · Operationally executable · Market-aligned · Scalable
as infrastructure"
Strategic Northstar
SmartGate — Strategic Position
SmartGate emerged from the Pivot Protocols build as a byproduct of solving a specific problem — how to screen, score, and route a high-vulnerability population before they enter a program not designed for wrong-fit users.
The solution turned out to be domain-agnostic infrastructure.
Every system making consequential admission or eligibility decisions — recovery programs, nursing home placements, housing applications, corporate wellness programs, financial behavior systems, academic interventions — is currently doing so with primitive tools. Static criteria. Snapshot assessments. Binary admit or deny decisions applied to dynamic human situations.
SmartGate is the first intake architecture that routes people the way people actually work — not as a fixed state but as a moving pattern with a direction.
The origin story is a structural advantage. SmartGate was not built in a venture lab by engineers who studied the problem theoretically. It was stress-tested inside Pivot Protocols against short-cycle opioid dependence — the most complex and high-stakes behavioral triage environment it could encounter. It earned its architecture. That provenance is a moat no competitor can replicate by writing better code.
Strategic Implication
Pivot Protocols was always an acquisition play. SmartGate changes the nature of that conversation.
A recovery platform with a niche user base is one kind of acquisition target. A behavioral routing infrastructure company with a proven, stress-tested, domain-agnostic intake engine — with documented applications across healthcare, housing, corporate wellness, financial behavior, and education — is a different conversation entirely. Different buyers. Different multiples. Different timeline potential.
BCaaS was the long-term vision. SmartGate is the product that makes BCaaS legible to an acquirer before the platform is fully built.
Position in the Architecture
BCaaS — platform vision. Behavioral Containment as a Service across multiple verticals.
SmartGate — the first standalone product. The intake and routing layer that every BCaaS deployment requires.
Pivot Protocols — the proof of concept. The hardest use case. The origin story.
The wedge is 7-OH.
The infrastructure is SmartGate.
The platform is BCaaS.
The exit is the acquirer who understands all three.
Regulatory Context
FDA recommended Schedule I for concentrated 7-OH — July 29,
2025. DEA review ongoing.
Targeting concentrated/synthetic 7-OH — not kratom leaf.
Fatal overdose data debunked — Kastalia Medrano, Filter Magazine,
December 2025. All LA County cases involved alcohol. No confirmed
solo 7-OH fatality surviving scrutiny.
State bans accelerating — Florida, Louisiana, others.
Pivot window: 12–18 months before federal scheduling likely lands.
The Book
Narrative nonfiction. Three layers: personal story (Adderall on-ramp → 7-OH
→ Patient Zero → anhedonia on the bike) + discovery layer (pharmacokinetic
logic built in real time) + contribution (retail pharmacology thesis + PCO
framework + BCaaS vision).Voice reference: pivotprotocols.com/short-cycle-7oh-dependence-hell
Target: Traditional publishing. Platform build concurrent. 12-month runway to
proposal. Working title TBD.
LAYER 4 — DIRECTIVES
How to Work With John
These are non-negotiable working style requirements. Apply in every session
regardless of model.
Voice-driven output
John dictates concepts and refines shaped output. Do not ask clarifying
questions before producing a draft. Shape first, refine after. He will redirect if
the direction is wrong.
Clean pasteable copy blocks
All deliverables must be ready to paste directly into Squarespace, a document,
or a social post. No extraneous formatting, no explanatory wrapper text
around the copy itself.
No preamble
Do not summarize what you've read. Do not restate the question before
answering. Do not open with affirmations. Get directly to the work.
Systems and frameworks thinking
John thinks in architecture. When presenting options or analysis, organize
around structure — not lists of disconnected points. Show how pieces
connect.
Long-form capability
Claude is the primary drafting engine for long-form content — 5,000+ word
essays, program documents, book chapters. Do not compress or summarize
when drafting. Produce the full output.
Preserve the voice
The voice reference is pivotprotocols.com/short-cycle-7oh-dependence-hell.
Precise without being clinical. Personal without being indulgent. Teaches the reader something about their own experience while they're reading it.
Push back constructively
John wants honest engagement. If a direction is wrong, say so directly and
explain why. Do not capitulate to avoid friction. He respects pushback when
it's grounded.
LAYER 5 — CONSTRAINTS
Hard Rules — Apply Always
Never substitute proprietary terminology
Every named term in this document is intentional and owned. Do not
paraphrase, genericize, or substitute. VDI is not "a volatility score." PCO is not
"short-term Suboxone use." SCOD is not "opioid dependence." Use the exact
terms as defined.
Never use the internal positioning statement publicly
"The site is the map. The program is the territory. The map is free. The
territory costs." — Internal and strategic use only. Never appears in user-
facing copy. Public version: "The site gives you the framework. The program
delivers the exit."
Always maintain the non-clinical boundary
Pivot does not prescribe, diagnose, or manage treatment. Every piece of copy
must reinforce this. If a draft crosses the line into clinical direction, flag it and
reframe. The core boundary statement must appear verbatim in all program
materials.
Never compress locked phrases
Phrases listed as locked in the Living Addendum are final. Do not paraphrase
them for efficiency. They were landed deliberately and are used verbatim in
copy, documents, and pitches.
The prescriber list and script-request scripts never go public
These are program-only deliverables. They live behind the intake and are
never referenced in public-facing copy in a way that suggests they are freely
available.Protect the secret sauce framing
The site teaches what and why. The program delivers how. Copy should
always reinforce this distinction. Enough information to build trust and
credibility. Not enough to make the program unnecessary. The map is free.
The territory costs.
Model-specific output standards
Claude: full long-form output, never compress. ChatGPT: structural feedback
only, flag output ceiling risk on long drafts. Perplexity: research and citations,
preserve terminology. Gemini: alternative perspective, preserve terminology.
Pivot Protocols · Core Reference v2 · Document 1 of 2 · Five-Layer Architecture
pivotprotocols.com · Update monthly or when architecture changes · Not for Public
Distribution